Experience in the Cationorm® use in the treatment of dry eye syndrome in patients after adenoviral keratoconjunctivitis

Cover Page

Abstract


The dry eye syndrome ranges among widespread and persisting ophthalmic diseases. It is also called a disease of civilization. Among the causes particularly often leading to the dry eye syndrome adenoviral infection has to be listed. Over the last years, in Saint Petersburg, an increasing incidence rate of the epidemic adenoviral keratoconjunctivitis is noted, which is proceeding in severe membranous and infiltrative forms, involving the cornea. Occurring therewith secondary dry eye syndrome demands using effective medications. In the article, the experience in Cationorm® (Santen, Japan) clinical use for secondary dry eye syndrome treatment is disclosed.


Vitaly O. Sokolov

Diagnostic center No 7 (ophthalmological) for adults and children

Author for correspondence.
Email: tarvos50@rambler.ru

Russian Federation, Saint Petersburg

MD, PhD, head of the center

Natalya V. Morozova

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, PhD, deputy head of the center

Galina V. Polovinkina

Diagnostic center No 7 (ophthalmological) for adults and children

Email: Polovinkina.g.v@yandex.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist, head of ophthalmology department No 1

Mariya L. Borisova

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist

Inna N. Zvontsova

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist

Latifa M. Gasymzade

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist

Yuliya A. Kulikova

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist

Dina R. Shtupun

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist

Ol’ga S. Batynkova

Diagnostic center No 7 (ophthalmological) for adults and children

Email: morozova_dc7@mail.ru

Russian Federation, Saint Petersburg

MD, ophthalmologist

  1. Астахов Ю.С., Рикс И.А. Современные методы диагностики и лечения конъюнктивитов. – СПб., 2007. – 68 с. [Astakhov YuS, Riks IA. Sovremennye metody diagnostiki i lecheniya kon’’yunktivitov. Saint Petersburg; 2007. 68 p. (In Russ.)]
  2. Азнабаев М.Т., Гафурова Л.Г., Мальханов В.Б. Аденовирусные и хламидийные заболевания глаз. – Уфа, 1995. – 110 с. [Aznabaev MT, Gafurova LG, Mal’khanov VB. Adenovirusnye i khlamidiynye zabolevaniya glaz. Ufa; 1995. 110 p. (In Russ.)]
  3. Майчук Д.Ю. Вирусные конъюнктивиты и кератоконъюнктивиты // Синдром «красного глаза»: практическое руководство для врачей-офтальмологов. – М., 2010. – С. 31–38. [Maychuk DYu. Virusnye kon’’yunktivity i keratokon’’yunktivity In Sindrom “krasnogo glaza”: prakticheskoe rukovodstvo dlya vrachey-oftal’mologov. Moscow; 2010. P. 31–38. (In Russ.)]
  4. Майчук Д.Ю., Васильева О.А., Пронкин И.А. Результаты длительного применения местных кортикостероидов для лечения инфильтративной формы аденовирусного кератоконъюнктивита // Клиническая офтальмология. – 2014. – № 1. – С. 23–25. [Maychuk DYu, Vasil’yeva OA, Pronkin IA. Rezul’taty dlitel’nogo primeneniya mestnykh kortikosteroidov dlya lecheniya infil’trativnoy formy adenovirusnogo keratokon’’yunktivita. Klinicheskaya oftal’mologiya. 2014;(1):23-25. (In Russ.)]
  5. International Dry Eye Workshop (DEWS). The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surface. 2007;5:75-92. doi: 10.1016/S1542-0124(12)70081-2.
  6. Amrane M, et al. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – a randomized comparative study. J Fr Ophthalmol. 2014;37(8):589-98. doi: 10.1016/j.jfo.2014.05.001.
  7. Lallemand F, et al. Successfully Improving Ocular Drug Using the Cationic Nanoemulsion, Novasorb. J Drug Devil. 2012: Article ID604204, 16 pages. doi: 10.1155/2012/604204604204.

Supplementary files

There are no supplementary files to display.

Views

Abstract - 909

PDF (Russian) - 321

PlumX

Comments on this article

  • internal
    "Goudy Rosalee" (08.10.2018)
  • spell
    "Earwood Stanton" (08.10.2018)
  • connection
    "Nelia Dolores" (09.10.2018)
  • disagree
    "Valencia Johnette" (09.10.2018)
  • walk
    "Annamaria Leonida" (09.10.2018)
  • many
    "Sadie Mantooth" (09.10.2018)
  • exuberant
    "Bev Cataldo" (09.10.2018)
  • scene
    "Aichele Kirk" (09.10.2018)
  • absurd
    "Maclean Cline" (09.10.2018)
  • exuberant
    "Brooke Ritchie" (10.10.2018)
  • quicksand
    "Mariko Voltz" (10.10.2018)
  • compete
    "January Nurse" (10.10.2018)
  • cough
    "Alysa Lippard" (10.10.2018)
  • disagree
    "Rosena Roland" (10.10.2018)
  • disapprove
    "Kimble Grayce" (10.10.2018)
  • stove
    "Ruben Voltz" (10.10.2018)
View all comments

Copyright (c) 2017 Sokolov V.O., Morozova N.V., Polovinkina G.V., Borisova M.L., Zvontsova I.N., Gasymzade L.M., Kulikova Y.A., Shtupun D.R., Batynkova O.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.